StockData
Immunic, Inc. logo

Immunic, Inc. (IMUX) stock

IMUXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$7.33+0.10 (+1.38%)

Close on Nov 17, 2026Market cap $100.01MP/E –Yield 0.00%

Immunic operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Immunic's operating cash flow for the twelve months ending Jun 30, 2026 was -$87.72M. For fiscal 2025 it was -$85.81M. The highest annual figure on record is -$9.24M in fiscal 2012.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$85.81M–
FY2024Dec 31, 2024-$84.77M–
FY2023Dec 31, 2023-$70.83M–
FY2022Dec 31, 2022-$65.14M–
FY2021Dec 31, 2021-$83.23M–
FY2020Dec 31, 2020-$46.12M–
FY2019Dec 31, 2019-$28.55M–
FY2018Dec 31, 2018-$9.74M–
FY2017Dec 31, 2017-$40.40M–
FY2016Dec 31, 2016-$35.77M–
FY2015Dec 31, 2015-$49.95M–
FY2014Dec 31, 2014-$40.83M–
FY2013Dec 31, 2013-$28.65M–
FY2012Dec 31, 2012-$9.24M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$31.00M–
Q1 FY2026Mar 31, 2026-$17.30M–
Q4 FY2025Dec 31, 2025-$19.28M–
Q3 FY2025Sep 30, 2025-$20.14M–
Q2 FY2025Jun 30, 2025-$24.61M–
Q1 FY2025Mar 31, 2025-$21.78M–
Q4 FY2024Dec 31, 2024-$22.96M–
Q3 FY2024Sep 30, 2024-$20.80M–
Q2 FY2024Jun 30, 2024-$17.04M–
Q1 FY2024Mar 31, 2024-$23.97M–
Q4 FY2023Dec 31, 2023-$14.03M–
Q3 FY2023Sep 30, 2023-$17.31M–
Q2 FY2023Jun 30, 2023-$19.98M–
Q1 FY2023Mar 31, 2023-$19.51M–
Q4 FY2022Dec 31, 2022-$15.10M–
Q3 FY2022Sep 30, 2022-$13.60M–
Q2 FY2022Jun 30, 2022-$15.76M–
Q1 FY2022Mar 31, 2022-$20.68M–
Q4 FY2021Dec 31, 2021-$23.68M–
Q3 FY2021Sep 30, 2021-$17.60M–
Q2 FY2021Jun 30, 2021-$29.01M–
Q1 FY2021Mar 31, 2021-$12.95M–
Q4 FY2020Dec 31, 2020-$13.96M–
Q3 FY2020Sep 30, 2020-$11.91M–
Q2 FY2020Jun 30, 2020-$9.23M–
Q1 FY2020Mar 31, 2020-$11.03M–
Q4 FY2019Dec 31, 2019-$6.27M–
Q3 FY2019Sep 30, 2019-$5.98M–
Q2 FY2019Jun 30, 2019-$10.99M-223.9%
Q1 FY2019Mar 31, 2019-$5.32M–
Q4 FY2018Dec 31, 2018-$3.45M–
Q3 FY2018Sep 30, 2018-$2.09M–
Q2 FY2018Jun 30, 2018$8.87M–
Q1 FY2018Mar 31, 2018-$13.07M–
Q4 FY2017Dec 31, 2017-$9.92M–
Q3 FY2017Sep 30, 2017-$9.42M–
Q2 FY2017Jun 30, 2017-$10.15M–
Q1 FY2017Mar 31, 2017-$10.91M–
Q4 FY2016Dec 31, 2016-$9.10M–
Q3 FY2016Sep 30, 2016-$7.89M–

More Immunic figures

See a number that looks wrong?